Sands Capital Management, LLC Karuna Therapeutics, Inc. Transaction History

Sands Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 03, 2021	SELL	$101.2 - $125.87 $38.5 Million - $47.9 Million	-380,307 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$107.45 - $135.95 $5.22 Million - $6.61 Million	-48,588 Reduced 11.33%	380,307 $43.4 Million
Q4 2020 Feb 17, 2021	BUY	$75.23 - $109.23 $32.3 Million - $46.8 Million	428,895 New	428,895 $43.6 Million
Q4 2020 Feb 16, 2021	SELL	$75.23 - $109.23 $32.3 Million - $46.8 Million	-428,895 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$11.44 - $123.99 $1.72 Million - $18.6 Million	-150,000 Reduced 25.91%	428,895 $32.3 Million
Q2 2019 Aug 14, 2019	BUY	$20.02 - $20.02 $11.6 Million - $11.6 Million	578,895 New	578,895 $9.17 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Sands Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sands Capital Management, LLC with notifications on news.